top of page

COVID-19 Testing.





Enabling Our Clients

As businesses reopen, students get back into the classroom, sports teams look to compete, and companies aim to provide seamless service for their customers and clients, safety and confidence are top of mind. In an uncertain time, CoVerify Health is a highly reliable COVID-19 testing platform that is mindful of the health and business needs of our clients and communities.

What We Offer


COVID-19 Testing

CoVerify Health works with CLIA-certified clinical laboratory partners that have secured the FDA’s emergency use authorization (EUA) for Molecular-Based Tests (LDTs) for the Coronavirus Disease 2019 (COVID-19).  



Our technology partners provide our customers with a platform for registration and consent, reporting symptoms, tracking and scheduling testing, organizing test results, notifying clients of regional outbreaks and more. 



Utilize our qualified service provider network to order tests and coordinate sample collection efforts at a convenient location.  Test kits arrive in as little as 24 hours.



Ongoing support to help design and complete your COVID-19 testing strategy.  

We understand time is of the essence. Companies receive test results in as little as 24-48 hours from when tests are received by the lab.

Our Process


3. Testing

Testing is done at a location that works best for you and your employees. Each employee can be initially tested prior to returning to work with subsequent testing scheduled in advance. Alternatively, testing can be scheduled on an as needed basis.

Both the employer and the individual tested are notified of test results and can immediately access reports via email notifications or through a secure online portal.

4. Results

5. Follow-up

CoVerify Health schedules regular check-ins to continue to help guide your company’s COVID-19 testing strategy, enabling you to keep your employees feeling safe and confident. 

Our Process

CoVerify Health collects information about your business and works with you to develop your COVID-19 testing strategy.

1. Consult

Guidance to help you effectively communicate your COVID-19 testing plan to your employees. Consent forms are signed. Tests are ordered.

2. Enrollment

  • How accurate are the genetic (“PCR”) COVID-19 test results provided by CoVerify lab partners?
    CoVerify partners exclusively with best in class labs that use highly accurate, PCR testing to detect the presence of the COVID-19 virus. Each of our labs is CLIA certified, classified as one of America’s high throughput, high sensitivity COVID-19 testing labs, and has received Emergency Use Authorization status (EUA) from the FDA. The FDA requires PCR tests to detect trace amounts of the virus present with at least 95% certainty.
  • What is the difference between genetic (PCR) testing and antibody (serological) testing?
    PCR testing is currently the gold standard for determining if someone is infected with Covid-19. PCR tests detect the presence of the genetic material of the Covid-19 virus. As a result, the PCR test determines if an individual is currently infected by the virus. The serological test detects the presence of Covid-19 antibodies, which are an immune system's response to the virus. As a result, the serological test does not detect the current presence of the virus itself but the immune system's response to the virus. Even when antibodies are detected, results can be misleading and cannot be relied upon to diagnose Covid-19 infection or contagiousness.
  • Does an employee have to be symptomatic to be eligible for a test?
    No. All employees are eligible to be tested.
  • Who is responsible for collecting the samples that are tested for Covid-19?
    A technician/registered healthcare professional. CoVerify and our partner labs help facilitate the administration of the sample by connecting you with a local team of technicians and healthcare professionals who travel to your test site and are trained in the collection process.
  • How is a sample collected to be tested for COVID-19?
    A sample is collected by a qualified professional by inserting a sterile, one-time-use swab into the nose. The swab is then placed in a test tube and sealed into a specimen bag which is sent directly back to the lab.
  • How long does the sample collection process take?
    The entire sample collection process, from initial registration to completion, is typically done in a matter of a few minutes. Physically collecting a sample usually takes less than one minute.
  • How do employees prepare for the test?
    There is no preparation required.
  • If someone contracts COVID-19, are they then immune from contracting it again?"
    Uncertain. Researchers are working to determine whether someone can get sick more than once. Currently, there is no definitive answer.
  • What do we do if an employee receives a positive/negative test result?
    CoVerify Health will assist your company in developing a protocol that works for you and your employees. While each individual case is dependent on many variables, CoVerify helps companies strategically plan their communication to ensure employees understand and trust the procedure in advance of the tests and the results. If an employee tests positive, they are directed by their manager to stay home and self-isolate. The individual should then consult with their physician for further treatment if necessary. Retesting employees is advised to ensure that employees remain healthy and the workplace environment is safe.
  • How often should I test my employees?
    There are many factors that contribute to determining an appropriate testing strategy. CoVerify will help your organization optimize your near and long term testing protocol. Until a vaccine is available, regular testing will help employers stay informed and enable companies to make better decisions.


“Symptom monitoring is unlikely to detect more than about half of infections, and people may only develop symptoms days after being contagious.”

-Scott Gottlieb, MD, former FDA comm.

“The next steps are rapid testing and contact tracing.”

-Dr. Robert Bollinger, JHU Prof. of Infectious Diseases

The CDC has estimated that 35% of COVID-19 infections are asymptomatic.

Laboratory Customers

Contact Us Today:

bottom of page